January 2010
Worldwide Biotech;Jan2010, Vol. 22 Issue 1, p7
Trade Publication
No abstract available.


Related Articles

  • Novavax reports positive results from influenza vaccine study.  // PharmaWatch: Biotechnology;May2010, Vol. 9 Issue 5, p8 

    The article reports that biotechnology company Novavax Inc. reports positive results of its two-state pivotal study to evaluate the safety and immunogenicity of its unadjuvanted 2009 A/H1N1 virus-like particle pandemic influenza vaccine. According to the company, data shows that safety and...

  • A Caution About Giving Tamiflu To Children.  // Child Health Alert;Nov2009, Vol. 27, p4 

    The article discusses research on administering tamiflu to children. It references a study by R. M. Parker et al, published in the September 23, 2009 issue of the "New England Journal of Medicine." It reports the case of a 6-year-old with H1N1 flu who was prescribed with liquid Tamiflu but the...

  • Encephalitis in a child with H1N1 infection: First case report from India. Kulkarni, Rajesh; Kinikar, Aarti // Journal of Pediatric Neurosciences;Jul-Dec2010, Vol. 5 Issue 2, p157 

    Neurological complications have been described with seasonal influenza infection. We report encephalitis manifesting as seizures in a child with confirmed H1N1 infection. Treatment with oseltamivir was started. Child was discharged without any neurological sequelae.

  • Pharmacologic Considerations for Oseltamivir Disposition. Abdel-Rahman, Susan M.; Newland, Jason G.; Kearns, Gregory L. // Pediatric Drugs;2011, Vol. 13 Issue 1, p19 

    Across much of the world, pandemic H1N1 infection has produced a significant healthcare crisis, reflected in significant morbidity and mortality. Statistics reveal that infection-associated deaths among individuals without pre-existing conditions (e.g. immunosuppression) are clustered in...

  • H1N1 dosing and efficacy. Elliott, William T. // Primary Care Reports;Feb2010 Pharmacology Watch, p2 

    The article focuses on the studies that was published in the December 17, 2009 issue of "New England Journal of Medicine," which revealed that a dose of H1N1 vaccine is already effective for those 3 years-old and above. The first study included 240 individuals which were divided to receive 15...

  • Oseltamivir storage, distribution and dispensing following the 2009 H1N1 influenza outbreak in Mexico. Gutiérrez-Mendoza, Luis Meave; Schwartz, Brian; Méndez de Lirac, José de Jesús; Wirtz, Veronika J. // Bulletin of the World Health Organization;Oct2012, Vol. 90 Issue 10, p782 

    Problem During an influenza outbreak or pandemic, timely access to antivirals is essential to reduce disease severity and transmission. Best practices in antiviral procurement, storage, distribution, prescription and dispensing must be followed for prompt drug delivery. Approach Mexico...

  • Swine Flu - a Major Public Administration Challenge; Not Democrat or Republican, Says Incoming University of Maryland Public Policy Dean.  // Ascribe Newswire: Medicine;4/28/2009, p7 

    The article presents the comments of Dan Kettl, an expert on public administration, on the swine flu outbreak. According to Kettl, the administration of U.S. President Barack Obama, has to build partnerships across all levels of government, the health sector and with other nations to deal with...

  • Meeting the Demand for Vaccine Production.  // Pharmaceutical Processing;Jun2010, Vol. 25 Issue 6, p42 

    The article focuses on the partnership between Novartis Pharmaceuticals Corp. and ITT Pure-Flo to provide assurance that Novartis could meet all H1N1 pandemic vaccine demand requirements in the U.S. It notes that Andrew Mahoney, channel relationship manager at ITT Pure- Flo, was contracted to...

  • High-Dose N-Acetylcysteine Therapy for Novel H1N1 Influenza Pneumonia. Kang Yiu Lai; Wing Yiu Ng; Pik Kei Osburga Chan; Kit Fai Wong; Fanny Cheng // Annals of Internal Medicine;5/18/2010, Vol. 152 Issue 10, p687 

    The article focuses on a clinical observation relative to N-acetylcysteine treatment for H1N1 influenza pneumonia. It discusses the case of a woman presented with a novel H1N1 human swine influenza (H1N1) pneumonia wherein her health condition improved rapidly due to the high-dose of...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics